ATEA PHARMACEUTICALS INC (AVIR) Stock Income Statement
NASDAQ:AVIR - Nasdaq - US04683R1068 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 351.40M | 48.60M | 0.00 | |||
| Operating Expenses | 120.01M | 111.20M | 119.50M | 36.70M | 14.60M | |||
| Research and Development | 70.09M | 62.40M | 73.70M | 15.00M | 10.20M | |||
| Selling, General, and Administrative Expenses | 49.92M | 48.70M | 45.80M | 21.60M | 4.40M | |||
| Operating Income | -120.01M | -111.20M | 231.90M | 12.00M | -14.60M | |||
| Interest Income/Expense | 29.22M | 11.20M | 200.00K | 100.00K | 600.00K | |||
| Non Recurring Items | -44.15M | -19.50M | -93.50M | -23.00M | N/A | |||
| Income Before Taxes | -134.94M | -119.50M | 138.60M | -10.90M | -14.00M | |||
| Income Tax | 1.02M | -3.60M | 17.40M | N/A | N/A | |||
| Net Income | -135.96M | -115.90M | 121.20M | -10.90M | -14.00M | |||
| EBITDA | -119.59M | -110.90M | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.63 | -1.39 | 1.37 | -0.13 | -0.17 | |||
| Non GAAP EPS | -1.64 | -1.40 | 1.36 | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | 34.49% | -22.43% | N/A | |||
| Operating Profit Margin | N/A | N/A | 65.99% | 24.69% | N/A | |||
All data in USD